Overview
Jolanta Powierza-Sawicka practices in Bialystok, Poland. Ms. Powierza-Sawicka is rated as an Experienced expert by MediFind in the treatment of Nearsightedness. Her top areas of expertise are Nijmegen Breakage Syndrome, Atelosteogenesis Type 1, Ataxia-Telangiectasia, and Strabismus.
Her clinical research consists of co-authoring 31 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Nearsightedness.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Atelosteogenesis Type 1Ms. Powierza-Sawicka isAdvanced. Learn about Atelosteogenesis Type 1.
- Nijmegen Breakage SyndromeMs. Powierza-Sawicka isAdvanced. Learn about Nijmegen Breakage Syndrome.
- Experienced
- Ataxia-TelangiectasiaMs. Powierza-Sawicka isExperienced. Learn about Ataxia-Telangiectasia.
- Atrial FibrillationMs. Powierza-Sawicka isExperienced. Learn about Atrial Fibrillation.
- Brown SyndromeMs. Powierza-Sawicka isExperienced. Learn about Brown Syndrome.
- Chronic B-Cell Leukemia (CBCL)Ms. Powierza-Sawicka isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Granulomatous DiseaseMs. Powierza-Sawicka isExperienced. Learn about Chronic Granulomatous Disease.
- Chronic Lymphocytic Leukemia (CLL)Ms. Powierza-Sawicka isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).